Discovery of Potential Dual Inhibitors Against Lipases Rv0183 and Rv3802c for Tuberculosis Therapeutics

E-ISSN： 1875-628x|13|2|185-195

ISSN： 1570-1808

Source： Letters in Drug Design & Discovery, Vol.13, Iss.2, 2016-02, pp. : 185-195

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

M. tuberculosis H37Rv Infection of Chinese Rhesus Macaques

By Zhang Jing

Journal of Neuroimmune Pharmacology, Vol. 6, Iss. 3, 2011-09 ,pp. : 362-370

Springer Publishing Company

Access to resources Recommend Favorite

Mechanisms of bacterial acetohydroxyacid synthase (ahas) and specific inhibitors of Mycobacterium tuberculosis ahas as potential drug candidates against tuberculosis

Current Drug Targets, Vol. 16, Iss. 7, 2015-01 ,pp. : 689-699

Bentham Science Publishers

Access to resources Recommend Favorite

In-Silico Characterization of a Hypothetical Protein, Rv1288 of Mycobacterium tuberculosis Containing an Esterase Signature and an Uncommon LytE Domain

Current Computer - Aided Drug Design, Vol. 13, Iss. 2, 2017-04 ,pp. : 101-111

Bentham Science Publishers

Access to resources Recommend Favorite

Immunogenicity and Therapeutic Effects of pVAX1-rv1419 DNA from Mycobacterium tuberculosis

Current Gene Therapy, Vol. 16, Iss. 4, 2016-12 ,pp. : 249-255

Bentham Science Publishers

Access to resources Recommend Favorite

Universal RV vaccination not cost effective

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 557, 2008-01 ,pp. : 8-8

Adis International

Access to resources Recommend Favorite